Trial intelligence / Profile preview

TAP block with ropivacaine for post-operative pain after major gynaecological laparotomy

ACTRN12608000161325Phase 4Completed

Sponsor
James Griffiths
Start
Dec 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by James Griffiths. Primary endpoint: Pain score with forced expiration. Started Dec 2008; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12608000161325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12608000161325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call